You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0892 Progressive clinical benefit in chronic refractory gout patients achieving a persistent urate lowering effect from pegloticase treatment

Article metrics

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Crystal diseases, metabolic bone diseases and bone diseases other than osteoporosis
AB0892 Progressive clinical benefit in chronic refractory gout patients achieving a persistent urate lowering effect from pegloticase treatment
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to August 2024

AbstractFullPdf
Jun 2017401
Jul 20171200
Aug 20172602
Sep 20171000
Oct 20171402
Nov 20171000
Dec 20172601
Jan 20183406
Feb 2018600
Mar 20182003
Apr 2018400
May 20181000
Jun 20181003
Jul 20181400
Aug 20181200
Sep 20181202
Oct 2018402
Nov 2018803
Dec 20181401
Jan 2019602
Feb 2019200
Mar 2019203
Apr 2019001
May 2019104
Jun 2019602
Jul 2019202
Aug 2019402
Sep 2019401
Oct 2019603
Nov 2019003
Dec 2019400
Jan 2020400
Feb 2020200
Mar 2020202
May 2020002
Jun 2020400
Jul 20201005
Aug 2020404
Sep 2020800
Oct 2020200
Nov 2020601
Dec 2020600
Jan 2021001
Feb 2021403
Mar 2021003
Apr 2021805
May 2021001
Jun 2021001
Jul 20210015
Aug 2021001
Sep 2021003
Oct 20214010
Nov 20212014
Dec 2021401
Jan 2022201
Feb 2022401
Mar 2022001
Apr 2022001
May 202212011
Jun 20221503
Jul 20221000
Aug 2022603
Sep 2022209
Oct 2022402
Nov 2022602
Dec 2022601
Jan 20231602
Feb 2023400
Mar 2023600
Apr 2023001
May 2023402
Jun 2023001
Jul 2023202
Sep 2023001
Oct 2023201
Nov 2023102
Dec 20231402
Jan 2024200
Feb 2024600
Mar 20245061
Apr 202412015
May 2024702
Jun 2024700
Aug 20241101
Total5230249